Zenas BioPharma, Inc. Operating Lease, Expense
Zenas BioPharma, Inc. (ZBIO) reported Operating Lease, Expense of $200.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2024-11-12
- Zenas BioPharma, Inc. operating lease, expense for the quarter ending 2024-09-30 was $200.00K, a 33.33% decline year-over-year.
- Zenas BioPharma, Inc. operating lease, expense for the quarter ending 2023-09-30 was $300.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 9 month |
|---|---|---|
| 2024-09-30 | $200.00K 10-Q · filed 2024-11-12 | $600.00K 10-Q · filed 2024-11-12 |
| 2023-09-30 | $300.00K 10-Q · filed 2024-11-12 | $700.00K 10-Q · filed 2024-11-12 |